复星医药：H股--英文招股书.PDF

1、If you are in any doubt about any of the contents of this prospectus,you should obtain independent professional advice.上海復星 醫藥（集 團）股 份有限公司Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.*(a joint stock limited company incorporated in the Peoples Republic of China with limited liability)GLOBAL OFFERINGNu

2、mber of Offer Shares:336,070,000 H Shares(subject to theOver-allotment Option)Number of Hong Kong Offer Shares:33,607,000 H Shares(subject to adjustment)Number of International Offer Shares:302,463,000 H Shares(subject to adjustmentand the Over-allotment Option)Maximum Offer Price:HK$13.68 per Offer

3、 Share plus brokerageof 1%,SFC transaction levy of 0.003%andHong Kong Stock Exchange trading feeof 0.005%(payable in full on application,subject to refund)Nominal value:RMB1.00 per H ShareStock code:02196Joint Sponsors,Joint Global Coordinators,Joint Bookrunners and Joint Lead ManagersHong Kong Exch

4、anges and Clearing Limited,The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for thecontents of this prospectus,make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoe

5、ver arising from orin reliance upon the whole or any part of the contents of this prospectus.A copy of this prospectus,having attached thereto the documents specified in the paragraph headed Documents delivered to the Companies Registry in Appendix IX Documents Delivered to the Companies Registry an

6、d Available for Inspection to this prospectus,has been registered by the Registrar of Companies in Hong Kong asrequired by section 342C of the Companies Ordinance(Chapter 32 of the Laws of Hong Kong).The Securities and Futures Commission and the Registrar of Companies inHong Kong take no responsibil